Old Mission Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Old Mission Capital’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.87M	Buy	+95,591	New	+$3.17M	0.05%	184
2025 Q2	–	Sell	-75,043	Closed	-$1.89M	–	1162
2025 Q1	$1.89M	Buy	+75,043	New	+$1.9M	0.02%	250
2024 Q3	–	Sell	-14,124	Closed	-$350K	–	1561
2024 Q2	$350K	Buy	+14,124	New	+$401K	0.01%	857
2024 Q1	–	Sell	-33,980	Closed	-$1.38M	–	1431
2023 Q4	$1.38M	Buy	+33,980	New	+$1.25M	0.03%	452
2022 Q3	–	Sell	-24,076	Closed	-$1.34M	–	1104
2022 Q2	$1.34M	Buy	+24,076	New	+$1.43M	0.04%	454
2020 Q4	–	Sell	-113,719	Closed	-$16.1M	–	579
2020 Q3	$16.1M	Buy	113,719 +84,569	+290%	+$14.1M	1.27%	10
2020 Q2	$5.75M	Buy	+29,150	New	+$6.04M	0.41%	49
2020 Q1	–	Sell	-11,476	Closed	-$2.37M	–	425
2019 Q4	$2.37M	Sell	11,476 -1,009	-8%	-$187K	0.18%	85
2019 Q3	$1.91M	Sell	12,485 -1,937	-13%	-$317K	0.24%	67
2019 Q2	$1.86M	Buy	+14,422	New	+$1.71M	0.23%	82
2019 Q1	–	Sell	-34,209	Closed	-$3.14M	–	268
2018 Q4	$3.14M	Buy	34,209 +17,378	+103%	+$1.76M	0.32%	73
2018 Q3	$1.89M	Sell	16,831 -158	-0.9%	-$16.7K	0.33%	63
2018 Q2	$1.57M	Sell	16,989 -9,236	-35%	-$896K	0.17%	72
2018 Q1	$2.62M	Buy	+26,225	New	+$2.83M	0.35%	55
2017 Q4	–	Sell	-38,337	Closed	-$3.9M	–	452
2017 Q3	$3.9M	Buy	+38,337	New	+$3.35M	0.33%	64
2017 Q2	–	Sell	-37,034	Closed	-$3.19M	–	318
2017 Q1	$3.19M	Buy	37,034 +25,643	+225%	+$1.85M	0.35%	54
2016 Q4	$731K	Buy	+11,391	New	+$701K	0.06%	209
2015 Q4	–	Sell	-42,473	Closed	-$1.73M	–	309
2015 Q3	$1.73M	Buy	+42,473	New	+$2.45M	0.24%	71

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Old Mission Capital's LKFT Position: Q1 2026 in Review

Old Mission Capital opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026: 95,591 shares worth $2.87M. The stake represents 0.05% of the portfolio and ranks #184 among its holdings. This is a return to the name: Old Mission Capital previously reported a position in LKFT as recently as Q1 2025.

Old Mission Capital first reported a position in LKFT in Q3 2015 and has held it in 18 quarters since. The position peaked at $16.1M in Q3 2020. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Old Mission Capital held 95,591 shares of Lakefront Biotherapeutics American Depositary Shares worth $2.87M as of Q1 2026.
Lakefront Biotherapeutics American Depositary Shares was a new Old Mission Capital position in Q1 2026.
Lakefront Biotherapeutics American Depositary Shares made up 0.05% of Old Mission Capital's portfolio in Q1 2026, its #184 holding.
Old Mission Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and has held it in 18 quarters since.
Old Mission Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $16.1M in Q3 2020.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Old Mission Capital's 13F filing for Q1 2026, filed 15 May 2026.